Andreas Gäumann

4.4k citations

101 papers · 3.3k indexed · h-index 29

Impact in

Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Molecular Biology 41
- Angiogenesis and VEGF in Cancer 16
- PI3K/AKT/mTOR signaling in cancer 4
- Fibroblast Growth Factor Research 4
Pulmonary and Respiratory Medicine 29
- Sarcoma Diagnosis and Treatment 12
- Lung Cancer Treatments and Mutations 6

Co-authors: Moritz A. Konerding (8 shared papers)Edward K. Geissler (15 shared papers)Georg Breier (10 shared papers)E. Fait (2 shared papers)Hans J. Schlitt (10 shared papers)Arndt Hartmann (12 shared papers)Ferdinand Hofstaedter (6 shared papers)Wolfgang Dietmaier (7 shared papers)
Journals: Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (6 papers)International Journal of Cancer (5 papers)Molecular Cancer Therapeutics (3 papers)Oncology Reports (3 papers)Journal of Clinical Investigation (3 papers)
Partner nations: Germany Switzerland United States

In The Last Decade

Andreas Gäumann

96 papers receiving 3.2k citations

Peers

Countries citing papers authored by Andreas Gäumann

Since Specialization

Citations

This map shows the geographic impact of Andreas Gäumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Gäumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Gäumann more than expected).

Fields of papers citing papers by Andreas Gäumann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Gäumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Gäumann. The network helps show where Andreas Gäumann may publish in the future.

Co-authors

The 25 scholars most cited alongside Andreas Gäumann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas Gäumann Line = papers co-authored together Andreas Gäumann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Minute Gastric Sclerosing Stromal Tumors (GIST Tumorlets) Are Common in Adults and Frequently Show c-KIT Mutations The American Journal of Surgical Pathology ·Abbas Agaimy, Peter H. Wünsch, Ferdinand Hofstaedter, Hagen Blaszyk, Petra Rümmele, Andreas Gäumann, Wolfgang Dietmaier, Arndt Hartmann	2006	260
2	3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon British Journal of Cancer ·Moritz A. Konerding, E. Fait, Andreas Gäumann	2001	239
3	Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2 Journal of Clinical Investigation ·Peter Vajkoczy, Mohammad Farhadi, Andreas Gäumann, Regina Heidenreich, Ralf Erber, Andreas Wunder, Jörg C. Tonn, Michael D. Menger, Georg Breier	2002	185
4	Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor Thrombosis and Haemostasis ·Sabine Raab, Heike Beck, Andreas Gäumann, Ali Yüce, Hans‐Peter Gerber, Karl H. Plate, Hans‐Peter Hammes, Napoleone Ferrara, Georg Breier	2004	161
5	Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2 Journal of Clinical Investigation ·Peter Vajkoczy, Mohammad Farhadi, Andreas Gäumann, Regina Heidenreich, Ralf Erber, Andreas Wunder, Jörg C. Tonn, Michael D. Menger, Georg Breier	2002	147
6	p38 MAP Kinase—a molecular switch between VEGF‐induced angiogenesis and vascular hyperpermeability The FASEB Journal ·Katja Issbrücker, Hugo H. Marti, Stefan Hippenstiel, Georg Springmann, Robert Voswinckel, Andreas Gäumann, Georg Breier, Hannes C. A. Drexler, Norbert Suttorp, Matthias Clauss	2002	143
7	Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model International Journal of Cancer ·Sven A. Lang, Andreas Gäumann, Gudrun E. Koehl, Ulrike Seidel, Frauke Bataille, Dagmar Klein, Lee M. Ellis, Ulrich Bolder, Ferdinand Hofstaedter, Hans J. Schlitt, Edward K. Geissler, Oliver Stoeltzing	2007	138
8	Targeting Heat Shock Protein 90 in Pancreatic Cancer Impairs Insulin-like Growth Factor-I Receptor Signaling, Disrupts an Interleukin-6/Signal-Transducer and Activator of Transcription 3/Hypoxia-Inducible Factor-1α Autocrine Loop, and Reduces Orthotopic Tumor Growth Clinical Cancer Research ·Sven A. Lang, Christian Moser, Andreas Gäumann, Dagmar Klein, Gabriel Glockzin, Felix Popp, Marc H. Dahlke, Pompiliu Piso, Hans J. Schlitt, Edward K. Geissler, Oliver Stoeltzing	2007	119
9	Inhibition of heat shock protein 90 impairs epidermal growth factor–mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo Molecular Cancer Therapeutics ·Sven A. Lang, Dagmar Klein, Christian Moser, Andreas Gäumann, Gabriel Glockzin, Marc H. Dahlke, Wolfgang Dietmaier, Ulrich Bolder, Hans J. Schlitt, Edward K. Geissler, Oliver Stoeltzing	2007	95
10	Surgical treatment of pulmonary artery sarcoma Journal of Thoracic and Cardiovascular Surgery ·Eckhard Mayer, Jörg Kriegsmann, Andreas Gäumann, Hans‐Ulrich Kauczor, Manfred Dahm, U. Hake, Franz X. Schmid, H. Oelert	2001	85
11	Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-–small cell lung cancer Human Pathology ·Matthias Woenckhaus, Johannes Merk, Robert Stoehr, Frank Schaeper, Andreas Gäumann, Karsten Wiebe, Arndt Hartmann, Ferdinand Hofstaedter, Wolfgang Dietmaier	2007	72
12	Topographical Anatomy of Periprostatic and Capsular Nerves: Quantification and Computerised Planimetry European Urology ·Roman Ganzer, Andreas Blana, Andreas Gäumann, Jens‐Uwe Stolzenburg, Robert Rabenalt, Thorsten Bach, Wolf F. Wieland, Stefan Denzinger	2008	69
13	Circulating Vascular Progenitor Cells Do Not Contribute to Compensatory Lung Growth Circulation Research ·Robert Voswinckel, Tibor Ziegelhoeffer, Matthias Heil, Sawa Kostin, Georg Breier, Tanja Mehling, Rainer Haberberger, Matthias Clauss, Andreas Gäumann, Wolfgang Schäper, Werner Seeger	2003	67
14	Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity International Journal of Cancer ·Oleg Gluz, Peter J. Wild, Robert Meiler, Raihana Diallo‐Danebrock, Evelyn Ting, Svjetlana Mohrmann, G. Schuett, Edgar Dahl, Thomas J. Fuchs, Alexander Herr, Andreas Gäumann, Markus Frick, Christopher Poremba, Ulrike Nitz, Arndt Hartmann	2008	66
15	Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis European Journal of Cancer ·Christian Moser, Philipp Schachtschneider, Sven A. Lang, Andreas Gäumann, Akira Mori, Johann Zimmermann, Hans J. Schlitt, Edward K. Geissler, Oliver Stoeltzing	2008	62
16	Drug Resistance-associated Factors in Primary and Secondary Glioblastomas and their Precursor Tumors Journal of Neuro-Oncology ·Dominique S. Tews, A J Nissen, Claudia Külgen, Andreas Gäumann	2000	52
17	Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo Molecular Cancer Therapeutics ·Christian Moser, Sven A. Lang, Silvia Kainz, Andreas Gäumann, Stefan Fichtner‐Feigl, Gudrun E. Koehl, Hans J. Schlitt, Edward K. Geissler, Oliver Stoeltzing	2007	50
18	Fungal polysaccharopeptide inhibits tumor angiogenesis and tumor growth in mice Life Sciences ·Jack Ho, Moritz A. Konerding, Andreas Gäumann, Marco Groth, W.K. Liu	2004	49
19	Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes Molecular Cancer Therapeutics ·Sven Arke Lang, Philipp Schachtschneider, Christian Moser, Akira Mori, Christina Hackl, Andreas Gäumann, David Batt, Hans J. Schlitt, Edward K. Geissler, Oliver Stoeltzing	2008	46
20	Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategies Clinical & Experimental Metastasis ·Gudrun E. Koehl, Andreas Gäumann, Edward K. Geissler	2009	45

About Andreas Gäumann

Andreas Gäumann is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Surgery, having authored 101 papers that have together received 3.3k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (16 papers), Cancer, Hypoxia, and Metabolism (14 papers), Sarcoma Diagnosis and Treatment (12 papers), Cardiac tumors and thrombi (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Mechanisms and Therapy (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Fibroblast Growth Factor Research (4 papers). The work is most often cited by research in Gastroenterology (305 citations), Cancer Research (595 citations), Oncology (753 citations), Pulmonary and Respiratory Medicine (843 citations) and Molecular Biology (1.4k citations). Andreas Gäumann has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Moritz A. Konerding, Edward K. Geissler, Georg Breier, E. Fait, Hans J. Schlitt, Arndt Hartmann, Ferdinand Hofstaedter, Wolfgang Dietmaier, Sven A. Lang and Oliver Stoeltzing. Their work appears in journals such as Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, International Journal of Cancer, Molecular Cancer Therapeutics, Oncology Reports and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact